Adel Merah

Adel Merah

Auto-generated profile, based on publicly available information

Adel Merah

CHU de St-Etienne, Médecine Vasculaire et Thérapeutique, Saint Etienne Cedex, France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2019 in Respiratory Medicine and Research
Verified
Journal Article
Closed access
JCJ. Catella-Chatron
J. Catella-Chatron
AMA. Merah
A. Merah
EME. De Magalhaes
E. De Magalhaes
NMN. Moulin
N. Moulin
SAS. Accassat
S. Accassat
LBLaurent Bertoletti
Laurent Bertoletti

11 March 2016 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
PDF file
AMAdel Merah
Adel Merah
LBLaurent Bertoletti
Laurent Bertoletti
MGMouzayan Ginzarly
Mouzayan Ginzarly
DZDavid Zeltser
David Zeltser
MBManuel Barrón
Manuel Barrón
MMManuel Monreal
Manuel Monreal

7 September 2020 in European Respiratory Journal
Verified
Conference Paper
Closed access
MMMartin Murgier
Martin Murgier
LFLéa Fouillet
Léa Fouillet
EOEdouard Ollier
Edouard Ollier
AMAdel Merah
Adel Merah
NMNathalie Moulin
Nathalie Moulin
LBLaurent Bertoletti
Laurent Bertoletti
Background: Acute kidney injury (AKI) is a frequent complication of acute medical and surgical diseases. Recently, we found AKI to occur in one in three patients with pulmonary embolism (PE), being an increased risk of death and bleeding. Evolution of renal function in patients with AKI and PE is unknown. Aim: To report the proportion of patients with AKI who recover a normal renal function, after PE. Methods: In a post-hoc analysis of patients with symptomatic PE, prospectively included from September 2013 to October 2018, in whom AKI (KDIGO guidelines) was diagnosed at the time of PE, and with at least one Serum Creatinine value measurement through the follow-up. The primary outcome was the proportion of patients who recover from AKI, defined as disappearance of AKI criteria during follow-up (any creatinine assessment during the follow-up). Secondary outcomes were timing of recovery, and characteristics associated with AKI recovery during follow-up, in univariable and multivariable analysis. Results: Among the 270 patients with acute PE, 41 (15.19%, 95%CI [11.12-20.03]) had AKI at baseline. Thirty patients (73%, 95%CI [57-86]) recovered, 24 at day 7. Only presence of cancer was associated with no recovery, in univariate analysis. Conclusion: In PE patients with AKI, renal recovery is frequent and rapid. However, about a quarter of patients did not fully recover, at least 90 days after PE.